Haptens, immunogens, antibodies and conjugates to ketamine and its metabolites
US7371829B2 · kind B2 · utility
14Cited by
8References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 31, 2003 |
| Grant date | May 13, 2008 |
| Priority date | — |
| Expiry date | Jan 31, 2023 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/17
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides haptens, immunogens comprising such haptens coupled to an antigenicity-conferring carrier material, conjugates comprising such haptens bonded to a labelling agent as well as, antibodies raised against such immunogens and capable of binding with ketamine and its primary metabolite, norketamine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.